Abstract
Many people suffer from fibromyalgia (FM) without an effective treatment. They do not have a good quality of life and cannot maintain normal daily activity. Among the different hypotheses for its ethiopathophysiology, oxidative stress is one of the possibilities. Non-scientific information addressed to patients regarding the benefits of nutrition is widely available, and they are used to trying non-evidenced strategies. The aim of this paper is to find out what we know right now from scientific studies regarding fibromyalgia disease and nutritional status, diets and food supplements. A systematic search has been performed on Medline with a wide range of terms about these nutritional issues. The search has been made during 2009, for articles published between 1998 and 2008. Target population: people suffering from FM. Vegetarian diets could have some beneficial effects probably due to the increase in antioxidant intake. There is a high prevalence of obesity and overweight in patients, and weight control seems to be an effective tool to improve the symptoms. Some nutritional deficiencies have been described, it is not clear whether they are directly related to this disease or not. About the usefulness of some food supplements we found very little data, and it seems that more studies are needed to prove which ones could be of help. Dietary advice is necessary to these patients to improve their diets and maintain normal weight. It would be interesting to investigate more in the field of nutrition and FM to reveal any possible relationships.
Similar content being viewed by others
References
Wolfe F, Smythe HA, Yunus MB et al (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 33:160–172
Weir P, Harlan G, Nkoy F et al (2006) The incidence of fibromyalgia and its associated comorbidities: a population-based retrospective cohort study based on International Classification of Diseases, 9th revision codes. J Clin Rheumatol 12:124–128
Maquet D, Croisier JL, Crielaard JM (2000) Fibromyalgia in the year. Rev Med Liege 55(11):991–997
Lawrence R, Helmick C, Arnett F et al (1998) Estimates of the prevalence of artritis and selected músculoskeletal disorders in the United States. Artritis Rheum 41:778–799
Wolfe F, Ross K, Anderson J et al (1995) The prevalence and characteristics of fibromyalgia in the general population. Artritis Rheum 38:19–28
White KP, Speedchley M, Harth M et al (1999) The London fibromyalgia epidemiology study: the prevalence of fibromyalgia syndrome in London, Ontario. J Rheumatol 26(7):1570–1576
White KP, Harth M (2001) Classification, epidemiology, and natural history of fibromyalgia. Curr Pain Headache Rep 5(4):320–329
Valverde M, Juan A, Ribas B et al (2000) Prevalencia de la fibromialgia en la población española. Estudio EPISER 2000. Rev Esp Reumatol 27(5):157
Carmona L, Ballina J, Gabriel R et al (2001) EPISER study group. The burden of musculoskeletal diseases in the general population of Spain: results from a national survey. Ann Rheum Dis 60(11):1040–1045
Mas AJ, Carmona L, Valverde M et al (2008) EPISER study group. Prevalence and impact of fibromyalgia on function and quality of life in individuals from the general population results from a nationwide study in Spain. Clin Exp Rheumatol 26(4):519–526
Gamero F, Gabriel R, Carbonell J et al (2005) Pain in Spanish rheumatology outpatient offices: EPIDOR epidemiological study. Rev Clin Esp 205:157–163
Salaffi F, De Angelis R, Gras W et al (2005) Pain prevalence, investigation group (MAPPING) study. Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The MAPPING study. Clin Exp Rheumatol 23(6):819–828
Bannwarth B, Blotman F, Roué-Le Lay K et al (2008) Fibromyalgia síndrome in the general population of France: a prevalence study. Joint Bone Spine 24. [Epub ahead of print]
Felson DT (2008) Comparing the prevalence of rheumatic diseases in China with the rest of the world. Editorial. Arthritis Res Ther 10:106
Eisinger J, Plantamura A, Marie PA et al (1994) Selenium and magnesium status in fibromyalgia. Magnes Res 7(3–4):285–288
Reinhard P, Schweinsberg F, Wernet D et al (1998) Selenium status in fibromyalgia. Toxicol Lett 96–97:177–180
Ozgocmen S, Ozyurt H, Sogut S et al (2006) Antioxidant status, lipid peroxidation and nitric oxide in fibromyalgia etiologic and therapeutic concerns. Rheumatol Int 26:598–603
Bagis S, Tamer L, Sahin G et al (2005) Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder? Reumatol Int 25:188–190
Altindag O, Celik H (2006) Total antioxidant capacity and the severity of the pain in patients with fibromyalgia. Redox Rep 11(3):131–135
Pieczenik SR, Neustadt J (2007) Mitochondrial dysfunction and molecular pathways of disease. Exp Mol Pathol 83:84–92
Ozgocmen S, Ozyurt H, Sogut S et al (2006) Current concepts in the pathophysilogy of fibromyalgia: the potential role of oxidative stress and nitric oxide. Reumatol Int 26:585–597
Pall ML (2001) Common etiology of posttraumatic stress disorder, fibromyalgia, chronic fatigue syndrome and multiple chemical sensitivity via elevated nitric oxide/peroxynitrite. Med Hypotheses 57(2):139–145
Hänninen O, Kaartinen K, Rauma AL et al (2000) Antioxidants in vegan diet and rheumatic disorders. Toxicology 155:45–53
Donaldson MS, Speight N, Loomis S (2001) Fibromyalgia syndrome improved using a mostly raw vegetarian diet: an observational study. BMC Complement Altern Med 1:7
Vecchiet J, Cipollone F, Falasca K et al (2003) Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome. Neurosci Lett 335(3):151–154
Kennedy G, Spence VA, McLaren M et al (2005) Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. Free Radic Biol Med 39:584–589
Richards RS, Wang L, Jelinek H (2007) Erythrocyte oxidative damage in chronic fatigue syndrome. Arch Med Res 38:94–98
Zhang Z, Cherryholmes G, Mao A et al (2008) High plasma levels of MCP-1 and Eotaxin provide evidence for an immunological basis of fibromyalgia. Exp Biol Med 2333:1171–1180
Wallace DJ, Linker-Israeli M, Hallegua D et al (2001) Cytokines paly an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study. Rheumatology 40:74–749
Wallace DJ (2006) Is there a role for cytokine based therapies in fibromyalgia. Curr Pharm Des 12(1):17–22
Chakrabarty S, Zoorob R (2007) Fibromyalgia. Am Fam Physician 15; 76(2):247–254
Carville SF, Arendt-Nielsen S, Bliddal H et al (2008) EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis 67:536–541
Perrot S, Dickenson AH, Bennett RM (2008) Fibromyalgia: harmonizing science with clinical practice considerations. Pain Practice 8(3):177–189
Abeles M, Solitar BM, Pillinger MH et al (2008) Update on fibromyalgia therapy. Am J Med 121:555–561
Goldenberg DL, Burckhardt C, Crofford L (2004) Management of fibromyalgia síndrome. JAMA 292(19):2388–2395
Nishishinya MB, Rivera J, Alegre C et al (2006) Intervenciones no farmacológicas y tratamientos alternativos en la fibromialgia. Med Clin 12(8):295–299
Kaartinen K, Lami K, Hypen M et al (2000) Vegan diet alleviates fibromyalgia symptoms. Scand J Rheumatol 29(5):308–313
Bennet RM (2002) A raw vegetarian diet for patients with fibromyalgia. Curr Rheumatol Rep 4(4):284
Azad KA, Alam MN, Hag SA et al (2000) Vegetarian diet en the treatment of fibromyalgia. Bangladesh Med Res Counc Bull 26(2):41–47
Michalsen A, Riegert M, Lüdtke R et al (2005) Mediterranean diet or extended fasting’s influence on changing the intestinal microflora, immunoglobulin A secretion and clinical outcome in patients with rheumatoid artritis and fibromyalgia: an observational study. BMC Complement Altern Med 5:22
Smith JD, Terpening CM, Schmidt SOF et al (2001) Relief of fibromyalgia symptoms following discontinuation of dietary excitotoxins. Ann Pharmacother 35:702–706
Geenen R, Janssens EL, Jacobs JWG et al (2004) Dietary glutamate will not affect pain in fibromyalgia. J Rheumatol 31:785–787
Cairns BE, Svensson P (2005) Dietary glutamate and fibromyalgia. J Rheumatol 32(2):392–393; Author reply 393–394
Cymet TC (2003) A practical approach to fibromyalgia. J Natl Med Assoc 95:278–285
Arnold LM, Hudson JI, Keck PE et al (2006) Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry 67:1219–1225
Javaras KN, Harrison GP, Lalonde JK et al (2008) Co-occurrence of binge eating disorder with psychiatric and medical disorders. J Clin Psychiatry 69:266–273
Bennett RM, Jones J, Turk DC et al (2007) An internet survey of 2, 596 people with fibromyalgia. BMC Musculoskeletal Disorders 8:27
Patucchi E, Fatati G, Puxeddu A et al (2003) Prevalence of fibromyalgia in diabetes mellitus and obesity. Recent Prog Med 94:163–165
Yunus MB, Arslan S, Aldag JC (2002) Relationship between body mass index and fibromyalgia features. Scand J Rheumatol 31:27–31
Mengshoel AM, Haugen M (2001) Health status in fibromyalgia–a followup study. J Rheumatol 28:2085–2089
Shapiro JR, Anderson DA, Noff-Burg S (2005) A pilot study of the effects of behavioral weight loss treatment on fibromyalgia symptoms. J Psychosom Res 59:275–282
Neumann L, Lerner E, Glazer Y et al (2008) A cross-sectional study of the relationship between body mass index and clinical characteristics, tenderness measures, quality of life, and physical functioning in fibromyalgia patients. Clin Rheumatol 27(12):1543–1547
Shaver JLF, Wilbur J, Robinson P et al (2006) Women’s health issues with Fibromyalgia syndrome. J Women’s Health 9(15):1035–1045
Hooper MM, Stellato TA, Hallowell PT et al (2007) Musculoskeletal findings in obese subjects before and after weight loss following bariatric surgery. Int J Obes 31:114–120
Ananda A, Caterson I, Sambrook P et al (2008) The impact of obesity on the musculoskeletal system. Int J Obes 32(2):211–222
Lowe JC, Yellin J, Honeyman-Lowe G (2006) Female fibromyalgia patients: lower resting metabolic rates than matched healthy controls. Med Sci Monit 12(7):CR282-9
Loevinger B, Muller D, Alonso C et al (2007) Metabolic syndrome in women with chronic pain. Metab Clin Exp 56:87–93
Verheesen RH, Schweitzer CM (2008) Iodine deficiency, more than cretinism and goiter. Med Hypotheses 71:645–648
Pamuk GE, Pamuk ON, Set T et al (2008) An increased prevalence of fibromyalgia in iron deficiency anemia and thalassemia minor and associated factors. Clin Rheumatol 27:1103–1108
Swezey RL, Adams J (1999) Fibromyalgia: a risk factor for osteoporosis. J Rheumatol 26(12):2642–2644
Al-Allaf AW, Mole PA, Paterson CR et al (2003) Bone health in patients with fibromyalgia. Rheumatology 42:1202–1206
Plotnikoff GA, Quigley JM (2003) Prevalence of severe hipovitaminosis D in patients with persistent nonspecific musculoskeletal pain. Mayo Clin Proc 78:1463–1470
Block SR (2004) Vitamin D deficiency is not associated with nonspecific musculoskeletal pain syndromes including fibromyalgia. Mayo Clin Proc 79(12):1585–1591
Warner AE, Arnspiger SA (2008) Diffuse musculoskeletal pain is not associated with low vitamin D levels or improved by treatment with vitamin D. J Clin Rheumatol 14(1):12–16
Armstrong DJ, Meenagh GK, Bickle I (2007) Vitamin D deficiency is associated with anxiety and depression in fibromyalgia. Clin Rheumatol 26:551–554
Mouyis M, Ostor AJK, Crisp AJ et al (2008) Hypovitaminosis D among rheumatology outpatients in clinical practice. Rheumatology 47:1348–1351
Sendur OF, Tastaba E, Turan Y et al (2008) The relationship between serum trace elements levels and clinical parameters in patients with fibromyalgia. Rheumatol Int 28:1117–1121
Rosborg I, Hyllén E, Lidbeck J et al (2007) Trace element pattern in patients with fibromyalgia. Sci Total Environ 385:20–27
Eisinger J, Plantamura A, Marie PA et al (1994) Selenium and magnesium status in fibromyalgia. Magnes Res 7(3–4)–285–288
Schwarz MJ, Offenbaecher M, Neumeister A et al (2002) Evidence for an altered tryptophan metabolism in fibromyalgia. Neurobiol Dis 11:434–442
Torpy DJ, Papanicolaou DA, Lotsikas AJ et al (2000) Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6. A pilot study in fibromyalgia. Arthritis and Rheumatism 43(4):872–880
Maes M, Verkerk R, Delmeire L et al (2000) Serotoninergic markers and lowered plasma branched-chain-amino acid concentrations in fibromyalgia. Psychiatry Res 97:11–20
Rohr UD, Herold J (2002) Melatonin deficiencies in women. Maturitas 41(1):S85–S104
Caruso I, Puttini PS, Cazzola M et al (1990) Double-blind study of 5-hydroxytryptophan versus placebo in the treatment of primary fibromyalgia syndrome. J Int Med Res 18:201–209
Puttini PS, Caruso I (1992) Primary fibromyalgia syndrome and 5-HTP: a 90-day open study. J Int Med Res 20:182–189
Nicolodi M, Sicuteri F (1996) Fibromyalgia and migraine, two faces of the same mechanism. Serotonin as the common clue for pathogenesis therapy. Adv Exp Med Biol 398:373–379
Birdsall TC (1998) 5-Hydroxytriptohan: a clinically-effective serotonine precursor. Altern Med Rev 3(4):271–280
Merchant RE, Carmack CA, Wise CM (2000) Nutritional supplementation with chlorella pyrenoidosa for patients with fibromyalgia syndrome: a pilot study. Phytother Res 14:167–173
Merchant RE, Andre CA, Wise CM (2001) Nutritional supplementation with chlorella pyrenoidosa for fibromyalgia syndrome: a double-blind, placebo-controlled, crossover study. J Musculoskelet Pain 9(4)
Merchant RE, Andre CA (2001) A review of recent clinical trials of the nutritional supplement chlorella pyrenoidosa in the treatment of fibromyalgia, hypertension, and ulcerative colitis. Altern Ther Health Med 7(3):79–91
Rossini M, Di Munno O, Valentini G et al (2007) Double-blind, multicenter trial comparing acetyl-l-carnitine with placebo in the treatment of fibomyalgia patients. Clin Exp Rheumatol 25(2):182–188
Lister RE (2002) An open, pilot study to evaluate the potential benefits of coenzyme Q10 combined with Ginkgo Biloba extract in Fibromyalgia Syndrome. J Inter Med Res 30:195–199
Olson GB, Savage S, Olson J (2000) The effects of collagen hydrolysat on symptoms of chronic fibromyalgia and temporomandibular joint pain. Cranio 18(2):135–141
Bramwell B, Ferguson S, Scarlett N et al (2000) The use of ascorbigen in the treatment of fibromyalgia patients: a preliminary trial. Altern Med Rev 5(5):455–462
Jacobsen S, Danneskiold-Samsoe B, Andersen RB (1991) Oral S-adenosylmethionine in primary fibromyalgia. Double-blind clinical evaluation. Scand J Rheumatol 20(4):294–302
Fetrow CW, Avila JR (2001) Efficacy of the dietary supplement S-adenosyl-L-methionine. Ann Pharmacother 35:1414–1425
Dykman KD, Tone C, Ford C et al (1998) The effects of nutritional supplements on the symptoms of fibromyalgia and chronic fatigue syndrome. Integr Physiol Behav Sci 33(1):61–71
Werbach MR (2000) Nutritional strategies for treating chronic fatigue syndrome. Altern Med Rev 5(2):93–108
Acknowledgments
This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors. We thank Professor Casimiro Javierre and Ramon Segura, from University of Barcelona, for their help and advice during all the revision process to write this article. We are very grateful also to Rebecca Jeffree for her help in the linguistic revision of the text.
Conflict of interest statement
There are no conflict of interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Arranz, LI., Canela, MÁ. & Rafecas, M. Fibromyalgia and nutrition, what do we know?. Rheumatol Int 30, 1417–1427 (2010). https://doi.org/10.1007/s00296-010-1443-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-010-1443-0